Lamotrigine, an antiepileptic drug, inhibits 5-HT(3) receptor currents in NCB-20 neuroblastoma cells

抗癫痫药物拉莫三嗪可抑制NCB-20神经母细胞瘤细胞中的5-HT(3)受体电流。

阅读:1

Abstract

Lamotrigine is an antiepileptic drug widely used to treat epileptic seizures. Using whole-cell voltage clamp recordings in combination with a fast drug application approach, we investigated the effects of lamotrigine on 5-hydroxytryptamine (5-HT)(3) receptors in NCB-20 neuroblastoma cells. Co-application of lamotrigine (1~300 µM) resulted in a concentration-dependent reduction in peak amplitude of currents induced by 3 µM of 5-HT for an IC(50) value of 28.2±3.6 µM with a Hill coefficient of 1.2±0.1. These peak amplitude decreases were accompanied by the rise slope reduction. In addition, 5-HT(3)-mediated currents evoked by 1 mM dopamine, a partial 5-HT(3) receptor agonist, were inhibited by lamotrigine co-application. The EC(50) of 5-HT for 5-HT(3) receptor currents were shifted to the right by co-application of lamotrigine without a significant change of maximal effect. Currents activated by 5-HT and lamotrigine co-application in the presence of 1 min pretreatment of lamotrigine were similar to those activated by 5-HT and lamotrigine co-application alone. Moreover, subsequent application of lamotrigine in the presence of 5-HT and 5-hydroxyindole, known to attenuate 5-HT(3) receptor desensitization, inhibited 5-HT(3) receptor currents in a concentration-dependent manner. The deactivation of 5-HT(3) receptor was delayed by washing with an external solution containing lamotrigine. Lamotrigine accelerated the desensitization process of 5-HT(3) receptors. There was no voltage-dependency in the inhibitory effects of lamotrigine on the 5-HT(3) receptor currents. These results indicate that lamotrigine inhibits 5-HT(3)-activated currents in a competitive manner by binding to the open state of the channels and blocking channel activation or accelerating receptor desensitization.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。